11:00-12:15
   Moderators: A. Beeskow, Leipzig/DE; F. Molinari, Tourcoing/FR

Small structure, big impact: The secondary pulmonary lobule (interactive), J. Gruden, New Orleans/US
Lots of dots: Decoding the nodular pattern (interactive), A. Székely, Debrecen/HU

12:15-12:30 Break

12:30-14:45
   Moderators: A. Beeskow, Leipzig/DE; F. Molinari, Tourcoing/FR

Webs and lines: Making sense of the reticular pattern (interactive), F. Molinari, Valbonne/FR
Through the haze: Ground glass opacities demystified (interactive), A.R. Larici, Rome/IT
Solid truths: Interpreting consolidations on HRCT (interactive), F. Ahlfors, Västra Frölunda/SE

14:45-15:00 Break

15:00-16:30
   Moderators: A.R. Larici, Rome/IT; G. Milanese, Parma/IT

Holes in the picture: Cracking cystic lung disease (interactive), A. Oikonomou, Toronto/CA
Challenge accepted: Tackling fibrosing lung diseases (interactive), S. Palmucci, Catania/IT

16:30-16:45 Break

16:45-18:00
   Moderators: A.R. Larici, Rome/IT; G. Milanese, Parma/IT

Test your eye: HRCT challenge (interactive), R. Mura, Vienna/AT
Discussion

09:00-10:00
Introduction to Artificial Intelligence in Radiology
   Moderator: C. Jacobs, Nijmegen/NL

Key concepts and definitions, C. Jones, Brisbane/AU
How does deep learning work?, G. Langs, Vienna/AT
Generative AI, B. van Ginneken, Nijmegen/NL

10:00-10:15 Break

10:15-11:15
AI for thoracic oncology: Beyond lung cancer screening
   Moderator: G. Chassagnon, Paris/FR

AI in lung cancer screening: Current use and future directions, C. Jacobs, Nijmegen/NL
Predictive AI in lung cancer: From imaging to prognosis, G. Langs, Vienna/AT
EUCAIM, I. Blanquer, Valencia/ES

11:15-11:45 Industry sponsored slot
11:45-12:45 Break

12:45-13:45 AI for chest X-ray: Old modality, new tools
   Moderator: G. Langs, Vienna/AT

AI for chest X-ray interpretation, F. Gleeson, Oxford/UK
The tuberculosis screening use case: How AI can help for a global health challenge, B. van Ginneken, Nijmegen/NL
Can AI and chest X-ray replace ultra-low dose CT?, C. Jones, Brisbane/AU

13:45-14:15 Industry sponsored slot “Implementing Lung Cancer Screening in Europe: Progress, Challenges, and Pathways Forward”

Harmonizing Lung Cancer Screening Across Europe: Lessons from Early Adopters, S. Schmidt, Forchheim/DE
Austria’s Journey in Lung Cancer Screening Implementation: Insights and Opportunities, J. Löffler-Ragg, Natters/AT

14:15-14:30 Break

14:30-15:30 AI for diffuse lung diseases
   Moderator: C. Jones, Brisbane/AU

AI for interstitial lung diseases: Main applications, J.M. Goo, Seoul/KR
AI for bronchial diseases, G. Chassagnon, Paris/FR
The OSIC consortium, E.M. Estes-Cooper, Saugatuck/US

15:30-15:45 Break

15:45-16:45 Bringing AI into your radiology department
   Moderator: G. Langs, Vienna/AT

How to choose the right AI tool, G. Chassagnon, Paris/FR
Integration challenges: Making AI work within your hospital, D. Pinto Dos Santos, Frankfurt/DE
Business models for medical AI, J. Sufana, Vienna/AT

16:45-17:00 Break

17:00-18:00 Legal, ethical, and regulatory considerations
   Moderator: G. Chassagnon, Paris/FR

The EU AI act, M. Schmidbauer, Vienna/AT
Ethical reflections for a responsible use, K. Kwiatkowska, Vienna/AT

08:00-09:30 Educational Session: From evidence to action: Building a lung cancer screening programme
   Moderators: A. Christe, Bern/CH; A. Devaraj, London/UK

Essential elements of a screening programme, M. Silva, Parma/IT
Measuring success and sustaining impact: Data, outcomes and continuous improvement, S. Hare, London/UK
Nodule clinic – Nodule MDT and screening review meeting, A. Nair, London/UK
Round table discussion, All speakers

09:30-09:35 Break

09:35-10:05 Industry sponsored slot “Making AI Meaningful in Lung Disease: An Interactive Exploration of the ILA-ILD Transition”

Where Does Disease Begin? The Transition from ILA to ILD, E. Estes, Saugatuck/US

10:05-10:35 Coffee Break

10:35-11:35 Educational Session: Fibrosing lung disease: From diagnosis to disease monitoring
   Moderators: A. Nair, London/UK; D.S. Putrins, Riga/LV

Practical approach to fibrotic lung disease, J. Chung, San Diego/US
How to assess progression in fibrosing lung diseases, A. Devaraj, London/UK
The role of cryobiopsy and histology in the diagnosis of fibrosis lung diseases, V. Poletti, Forli/IT

11:35-11:40 Break

11:40-12:00 Opening Ceremony
   Moderator: H. Prosch, Vienna/AT

12:00-12:05 Break

12:05-13:05 Industry sponsored symposium “New CT and AI technologies in Lung Cancer Screening | From Accessibility to Nodule Management
   Moderator: M. Prokop, Nijmegen/NL

Lung Cancer Screening in Motion: Access, Efficiency, Innovation, A. Snoeckx, Edegem/BE
How technology can help in nodule management and incidental findings, C. Schaefer-Prokop, Amersfoort/NL
Live Q&A

13:05-13:35 Break

13:35-14:35 Scientific Session 1: Beyond the lung: Comprehensive AI applications in chest imaging
  Moderators: L. Morbée, De Pinte/BE; S. Tavernaraki, Athens/GR

Evaluating an AI first-reader workflow of baseline scans in a population-based lung cancer screening pilot, A. Gerris, Antwerp/BE
From CT to MRI: Robust Paediatric Thoracic Organ Segmentation Using a GIN-Augmented 3D U-Net, B. Lassen-Schmidt, Bremen/DE
AI-Based CT Analysis Identifies IMAT as an Independent Predictor of Vascular Calcification and Modulator of the Bone-Vascular Axis in COPD Patients, B.K. Budai, Heidelberg/DE
Can AI Screen for Low Bone Mineral Density on Routine Chest Radiographs? Insights from Irish and International Cohorts, T. Derksen, Cork/IE
Clinical Impact of AI Integration on the Primary Care CXR-to-Fast Track CT Diagnostic Pathway: A Longitudinal Audit, W. Ding, Leeds/UK
Novel AI strategy of combining large dataset training, population specific retraining and confidence estimation to improve pulmonary nodule malignancy risk assessment, E.M. Barbosa Jr, Philadelphia/US
Investigating Low-Dose CT Image Quality with Deep Learning Reconstruction Techniques and Interobserver Variability in Visual Grading, M. Oliveira Diniz, Gothenburg/SE
Discussion

14:35-14:45 Break

14:45-16:15 Educational Session: Finding lung cancer early: Pulmonary nodules in lung cancer screening
   Moderators: R. Mura, Vienna/AT; D. Penha, Liverpool/UK

How to establish a low-dose CT protocol, C. De Margerie-Mellon, Paris/FR
ESTI nodule management recommendations, M. Prokop, Nijmegen/NL
Lung cancer screening cases (interactive), G. Milanese, Parma/IT
AI as concurrent, second or first reader?, C. Jacobs, Nijmegen/NL
Discussion

16:15-16:45 Coffee Break

16:45-17:45 Educational Session: Lung cancer screening in Europe: Current perspectives and emerging strategies
   Moderators: J. Chorostowska, Warsaw/PL; M. Prokop, Nijmegen/NL

European status and major initiatives: SOLACE and ELCSA, H-U. Kauczor, Heidelberg/DE
Guidelines driving practice: European recommendations for lung cancer screening, T.G. Blum, Berlin/DE
Lessons from the field: Implementation studies across Europe, A. Kerpel Fronius, Budapest/HU
Recruitment strategies and patient engagement in lung cancer screening, J. Chorostowska, Warsaw/PL

17:45-17:50 Coffee Break

17:50-18:50 Educational Session: Lung cancer restaging: Imaging strategies and challenges
   Moderators: R. Dos Santos, Lisbon/PT; D. Shaham, Mevassert Zion/IL

Re-staging after systemic therapy: What radiologists need to know, L. Beer, Vienna/AT
Response assessment after radiotherapy: Mind the pitfalls, N. Screaton, Cambridge/UK
Imaging of post-surgical complications in thoracic oncology, T. Frauenfelder, Zurich/CH

08:00-09:30 Educational Session: Patterns of inflammation: Organising pneumonia, bronchiolocentric interstitial pneumonia and drug-induced pneumonitis
   Moderators: J. Coolen, Leuven/BE; J.R. Inácio, Lisbon/PT

Organizing pneumonia: Imaging features and clinical correlates, O. Moreh-Rahav, Tel Aviv/IL
Bronchiolocentric interstitial pneumonia: Imaging clues and diagnostic challenges, N. Sverzellati, Parma/IT
Drug-induced pneumonitis: The great imaging imitator, C. Romei, Pisa/IT
Discussion

09:30-10:05 Break
10:05-10:35 Coffee Break

10:35-11:35 Educational Session: Beyond the infiltrate: Radiologic perspectives on pneumonia
   Moderators: L. Beer, Vienna/AT; J. Ip, Lisbon/PT

Infectious Pneumonia: Classical and Emerging Imaging Patterns, R-I. Milos, Vienna/AT
We need to talk about tuberculosis, A.P. Parkar, Bergen/NO
Treatment-Resistant Pneumonia: Radiologic Differential Diagnosis and Pitfalls, E. Kocova, Hradec Kralove/CZ
Discussion

11:35-13:35 Break

13:35-14:35 Scientific Session 2: Advancing precision: Photon-counting CT and functional imaging in lung disease
   Moderators: N. Landini, Arezzo/IT; R.E. Ledda, Parma/IT

Spatial Mapping of Pulmonary Perfusion Defects in Acute Embolism: Automated Analysis of Non-Perfused Vessel Volume using Photon-Counting CT, A.M. Hunkemöller, Hannover/DE
3D PREFUL MRI reveals increased ventilation heterogeneity after pediatric lung transplantation, M. Speth, Hannover/DE
The role of FDG PET-CT for staging T1 part-solid lung nodules. More imaging, same decisions?, I. Telpova, Leeds/UK
Limitations of Opportunistic Osteoporosis Risk Assessment in Lung Cancer Screening using X-Ray-Comparable Photon-Counting CT, J. Kroschke, Zurich/CH
Node Reporting and Data System (Node-RADS) Evaluation for Regional Lymph Nodes in Surgically Treated Primary Lung Tumors, TBC
Is initial staging of patients with suspected lung cancer using a contrast CT chest safe practice?, TBC
Clinical Probability-Based Evaluation of an AI Algorithm for Pulmonary Embolism Detection on CT Pulmonary Angiography, M. Cotena, La Ciotat/FR
Discussion

14:35-14:45 Break

14:45-16:15 Educational Session: From images to insight: Advances in ILD
   Moderators: J. Gruden, New Orleans/US; H. Prosch, Vienna/AT

Speaking the same language: Fleischner Society consensus on ILD terminology, J.P. Kanne, Middleton/US
Everything new in ILDs? The new classification of interstitial pneumonias, S. Piciucchi, Bologna/IT
Artificial intelligence in ILD: Quantifying fibrosis and predicting progression, J.M. Goo, Seoul/KR
MRI and PET/CT in fibrosing lung disease: Emerging roles and clinical value, J. Biederer, Heidelberg/DE
Discussion

16:15-16:45 Coffee Break

16:45-17:45 Educational Session: Thoracic tumors: Imaging approaches and diagnostic challenges
   Moderators: R. Gill, New York/US; D. Murphy, Dublin/IE

Mediastinal masses: Characterisation and differential diagnosis, Y. Ahn, Seoul/KR
Mesothelioma: Imaging features and diagnostic pitfalls, I. Hartmann, Rotterdam/NL
MRI as problem solving tool in thoracic oncology, Y.J. Jeong, Busan/KR

17:45-17:50 Break

17:50-18:50 Young ESTI Committee Session “Mentorship, Future Skills & the Next Generation of Thoracic Radiologists”
   Moderators: G. Cicchetti, Rome/IT; D. Kifjak, Vienna/AT; E. Pompe, Utrecht/NL; I. Saab, Geneva/CH

Welcome & Introduction, G. Cicchetti, Rome/IT
Mentorship in Thoracic Radiology, D. Kifjak, Vienna/AT; H. Prosch, Vienna/AT
“Future Skills for Thoracic Radiologists. Skill N1: Interdisciplinary communication – How to speak the same language between radiologists and how to communicate with pathologists, pulmonologists, and surgeons”, G. Milanese, Parma/IT
Quiz (interactive), D. Kifjak, Vienna/AT; H. Prosch, Vienna/AT
Discussion

15:20-16:20 Industry Workshop 1

07:30-08:00 ESTI General Assembly

08:00-09:30
Educational Session: Hot topic in fibrosing lung diseases
   Moderators: E. Van Beek, Edinburgh/UK; J. Wakulinski, Warsaw/PL

Interstitial lung abnormalities (ILA): From incidental finding to clinical significance, S. Desai, London/UK
Connective tissue disease-related ILD: Imaging clues and diagnostic challenges, C. Schaefer-Prokop, Amersfoort/NL
Progressive pulmonary fibrosis (PPF): Imaging biomarkers and prognostic indicators, G. Cicchetti, Rome/IT
Discussion

09:30-09:40 Break

09:40-10:10 Crazy Paving Pattern: Cracking the Differential Diagnosis (interactive)
   H. Prosch, Vienna/AT

10:10-10:40 Coffee Break

10:40-11:40 The great Thoracic Imaging Quiz: Pitfalls, pearls and surprises
   Moderators: H. Gietema, Maastricht/NL; E. Muscogiuri, Leuven/BE

The challenging pulmonary CT pattern: Pitfalls, pearls and surprises (interactive), C. Schaefer-Prokop, Amersfoort/NL
The challenging oncologic patient: Pearls and pitfalls (interactive), C. Pozzessere, Lausanne/CH
The challenging acute aorta: Pearls and pitfalls (interactive), S. Patel, Saline/US

11:40-11:50 Break

11:50-12:50 Industry sponsored symposium ” Advances in Photon Counting CT of the lung utilizing high concentration contrast media”
   Moderator: C. Schaefer-Prokop, Hanover/DE

High-Concentration Contrast in Chest CT: Technical Setup, Image Quality, and Clinical Value in Pulmonary Vascular Imaging, T. Frauenfelder, Zurich/CH
Functional Lung Imaging in CTEPH: Perfusion Quantification, PBV Mapping, and Correlation with Ventilation, H. Shin, Hanover/DE

12:50-13:20 Break

13:20-14:20 Scientific Session 3: Lung cancer screening: Refining the screening pathway: Protocols, guidelines and performance
   Moderators: E.M. Barbosa Jr, Philadelphia/US; A.P. Parkar, Bergen/NO

Associations Between Emphysema Severity, Sputum Biomarkers, and Cell Composition in Smokers With and Without COPD, J. Zuchowska, Warszawa/PL
AI-based Automated Coronary Artery Calcification Quantification for Accurate and Efficient Reporting in Lung Cancer Screening: Comparison with Semi-automated and Visual Assessment, J. Kroschke, Zurich/CH
Impact of applying Lung-RADS versus ESTI nodule management recommendations to baseline scans in a population-based lung cancer screening pilot, A. Gerris, Antwerp/BE
Cough Before You Scan: A Simple Maneuver Could Reduce Mucus-Iduced Indeterminate Airways Nodules In Lung Cancer Screening, C. Bettaieb, Lausanne/CH
Cyst-related lung cancers and Lung-RADS v2022 in three screening trials, TBC
Beyond the lungs: AI-enabled detection of hepatic steatosis on low-dose chest CT in a european lung cancer screening population, C. Pozzessere, Lausanne/CH
Education and Training in Lung Cancer Screening: Results from a European Survey, R. Mura, Vienna/AT
Discussion

14:20-14:25 Break

14:25-15:55 Educational Session: Airways: Anatomy, function and imaging essentials
   Moderators: R.E. Ledda, Parma/IT; M. Puseljic, Graz/AT

Trachea: From congenital anomalies to acquired disorders, S. Tavernaraki, Athens/GR
Bronchiectasis: Imaging, etiology and emerging insights, M. Radiké, Liverpool/UK
Diseases of the small airways, F. Doellinger, Hamburg/DE
Discussion

15:55-16:15 Break

16:15-16:35 Honorary Lecture
   Moderator: H. Prosch, Vienna/AT

Pulmonary Embolism: Challenging the Myth of Easy Diagnosis, B. Ghaye, Brussels/BE

16:35-16:40 Coffee Break

16:40-18:10 Image Interpretation Session
   Moderators: J. Babar, Cambridgeshire/UK; D. Kifjak, Vienna/AT

Team 1: A. Devaraj, London/UK; A. Kerpel Fronius, Budapest/HU; R.E. Ledda, Parma/IT; E. Pompe, Utrecht/NL
Team 2: P-Y. Brillet, Bobigny/FR; G. Cicchetti, Rome/IT; D. Manos, Halifax/CA; C. Schaefer-Prokop, Amersfoort/NL

08:00-09:30 Educational Session: ESTI meets the French Society of Thoracic Imaging: Pulmonary embolism and pulmonary hypertension
   Moderators: R-I. Milos, Vienna/AT; J. Kroschke, Konstanz/DE

State-of-the-art imaging in pulmonary embolism, P. Habert, Marseille/FR
PE imaging: Diagnostic challenges and dilemmas, G. Aviram, Tel Aviv/IL
Pulmonary hypertension: Key imaging findings and radiologist’s role, O. Meyrignac, Le Kremlin-Bicêtre/FR
Discussion

09:30-10:10 Break
10:10-10:40 Coffee Break

10:40-11:40 Educational Session: Common challenges in thoracic imaging
   Moderators: G. Aviram, Tel Aviv/IL; S. Nikolova, Skopje/MK

Sarcoidosis: Imaging patterns and diagnostic pitfalls, C.A. Ridge, London/UK
Cystic lung disease: From imaging clues to diagnosis, P-Y. Brillet, Bobigny/FR
Micronodular patterns: Narrowing the differential, O. Hamer, Regensburg/DE

11:40-13:20 Break

13:20-14:20 Scientific Session 4: Interstitial lung diseases: AI-driven phenotyping and progression biomarkers
   Moderators: P. Khafagy, Fribourg/CH; S. Patel, Saline/US

CT manifestations of interstitial lung disease in Sjögren’s disease, M.M. Aabel, Oslo/NO
Head-to-Head Comparison of Three Visual CT Scores and Two Lung Texture Analysis Software in Systemic Sclerosis-Associated Interstitial Lung Disease, N. Landini, Rome/IT
iLARS: Imaging Biomarkers for Progression of Interstitial Lung Abnormalities to IPF, T. Schnitzler, Aarau/CH
Tracheal Remodeling as a Structural Marker of Progression in Fibrotic Interstitial Lung Disease, TBC
Interstitial Lung Abnormalities assessment in first-degree relatives of pathogenic Telomere-Related Gene variant carriers, using Deep Learning based Automated Quantification Tool, E. Caillat, Paris/FR
Chest HRCT Phenotypes in Cardiac Sarcoidosis: Analysis According to “High-resolution CT phenotypes in pulmonary sarcoidosis: A multinational Delphi consensus study”, J. Zuchowska, Warszawa/PL
Quantitative assessment of pulmonary fibrotic tissue volume in interstitial lung diseases using artificial intelligence, A. Oganesyan, Moscow/RU
Discussion

14:20-14:25 Break

14:25-15:55 Educational Session: Chest radiographs uncovered: Tips, tricks and pitfalls
   Moderators: T. Niemann, Baden/CH; O. Pettersson, Uppsala/SE

Common errors and cognitive biases in chest radiograph interpretation (interactive), A. Barker, Cambridge/UK
Small clues, big impact: Subtle findings that change clinical management (interactive), B. Heidinger, Vienna/AT
Test your eye: Chest radiograph quiz (interactive), N. Howarth, Chêne-Bougeries/CH
Discussion

09:40-10:40 Industry Workshop 2

11:50-12:50 Industry Workshop 3

08:00-09:00 Scientific Session 5: Bridging the gap: The impact of radiology reporting and AI on ILD clinical care
   Moderators: J. Arenas Jimenez, El Campello/ES; E. Pershina, Moscow/RU

Recognition of Interstitial Lung Disease on Thoracic CT: Impact of initial radiology report on time to specialist referral, R. Patel, London/UK
Relative “Normal Appearing Lung” Volume as a Novel CT Prognostic Biomarker in Patients with Fibrotic Interstitial Lung Disease, D. Juskanic, Nitra/SK
Ultra-High-Resolution Photon-Counting CT for ILD in Systemic Sclerosis, A. Hutt, Lille/FR
Interstitial lung abnormalities in oncologic patients with drug-induced pneumonitis: Prevalence, radiological and clinical correlations, R. Hayoz, Lausanne/CH
Diagnostic yield and complication predictors of CT-guided transthoracic lung biopsy: A single-center retrospective analysis, G.B. Sari, Ankara/TR
Impact of an AI Software in assessing progression of fibrotic pulmonary diseases: Comparison with expert visual scoring, M. Adorna, Catania/IT
Automated Detection of Interstitial Lung Abnormalities on Chest CT: Multi-Center Validation and Clinical Impact Evaluation, T. Schnitzler, Aarau/CH
Discussion

09:00-09:10 Break
09:10-09:40 Industry sponsored slot
09:40-10:10 Coffee Break

10:10-11:40 Educational Session: The road ahead: Conquering the challenges of lung cancer screening
   Moderators: A. Kerpel Fronius, Budapest/HU; S.M. Mak, London/UK

Incidental findings: The challenges, E.C. Bartlett, London/UK
Incidental findings: The opportunities, R.E. Ledda, Parma/IT
Addressing the broader challenges of lung cancer screening, R. Vliegenthart, Groningen/NL
Radiologists at the core – Shaping the future of lung cancer screening, A. Snoeckx, Edegem/BE

11:40-11:50 Coffee Break

11:50-12:10 Awarding Session
  Moderator: H. Prosch, Vienna/AT

Best Paper Award 2026 “Optimizing CT pulmonary angiography with patient-adaptive triggering – A novel approach for a “one-stop-shop” evaluation of pulmonary and aortic vasculature”, G. Almeida, Baden/CH
Oral Presentation Awards
Case of the day Winner
ESR Journal Presentation “European Radiology Cardiovascular and Thoracic”, H. Prosch, Vienna/AT; M.O. Wielpütz, Greifswald/DE

12:10-12:15 Break

12:15-13:15 Industry sponsored symposium “Tomorrow’s Lung Imaging – Photon counting CT and Lung MRI”
  Moderator: S. Schmidt, Forchheim/DE

Next-generation imaging of ILD with photon-counting CT, A. Dubbeldam, Leuven/BE
LungMaps – New horizons in functional lung MRI, J. Vogel-Claussen, Berlin/DE

13:15-13:45 Break

13:45-15:15 Educational Session: ESTI meets ESCR: When the heart meets the lung
   Moderators: A.P. Parkar, Bergen/NO; B. Wintersperger, Toronto/CA

Cardiooncology: Cardiac complications of systemic therapies, B. Wintersperger, Toronto/CA
Incidental Cardiovascular Abnormalities in Lung Cancer Screening CT, W.G. Jeong, Hwasun-gun, Jeollanam-do/KR
The thickened left ventricle, M. Pirnat, Maribor/SI
Acute cardiac chest pain, C. Loewe, Vienna/AT
Discussion

15:15-15:45 Coffee Break

15:45-16:45 Educational Session: Advances in thoracic imaging: Techniques and innovations
   Moderators: I. Pulzato, Liverpool/UK; I. Vlahos, Houston/US

Novel tracers in thoracic imaging, L. McIntosh, Worcester/US
Functional and quantitative MRI techniques, J. Vogel-Claussen, Hannover/DE
Photon counting CT – A game changer?, A. Dubbeldam, Leuven/BE

16:45-16:55 Break

16:55-17:00 Closing Ceremony
   Moderators: T. Frauenfelder, Zurich/CH; H. Prosch, Vienna/AT

08:00-09:00 Scientific Session 6: KSTR Oral Presentations
   Moderators: T. Frauenfelder, Zurich/CH; G.Y. Jin, Jeon-ju/KR

Deep Learning for Quantitative Segmentation of Interstitial Lung Abnormality on Chest CT, TBC
Prognostic Value of Cystic Morphologic Subtype and CT-Derived Volume Metrics in Lung Cancer Associated with Cystic Airspaces, S. You, Suwon/KR
Temporal CT Patterns and Predictive Imaging Biomarkers of Pulmonary Complications After Haematopoietic Stem Cell Transplantation, TBC
Post operative change in functional lung volume before and after lobar resection surgery: Correlation according to smoking history, H. Kwon, Daejeon/KR
AI-Quantified Maximum Aortic Diameters on Lung Cancer Screening CT Predict Subsequent Cancer Risk, S.R. Kang, Iksan/KR
Thoracoabdominal Lesions Crossing the Diaphragm: A Retrospective Imaging-Based Analysis, TBC
Chronic Pulmonary Graft-versus-Host Disease (GVHD): Clinical and Radiologic Insights, H. Kang, Busan/KR
AI-Based Quantitative CT-Derived Fibrosis Progression Predicts Progressive Pulmonary Fibrosis in CTD-ILD After COVID-19, B. Nam, Seoul/KR
Discussion

09:00-09:40 Break
09:40-10:10 Coffee Break

10:10-11:40 Educational Session: ESTI meets the International Association for the Study of Lung Cancer (IASLC)
   Moderators: J.M. Goo, Seoul/KR; H. Prosch, Vienna/AT

T-Staging in lung cancer: Challenges and pitfalls (interactive), R. Gill, New York/US
Lymph node staging: Mistakes to avoid (interactive), I. Vlahos, Houston/US
Imaging of metastatic disease in lung cancer (interactive), E. Coche, Brussels/BE
Discussion

11:40-13:45 Break

13:45-15:15 Educational Session: AI in thoracic imaging: Friend or foe?
   Moderators: P-Y. Brillet, Bobigny/FR; Y. Simargi, Jakarta Barat/IN

AI for pulmonary nodule detection and management, TBC
AI in the diagnosis and quantification of interstitial lung diseases, G. Chassagnon, Paris/FR
AI applications in COPD: From imaging to clinical decision support, M. Occhipinti, Pisa/IT
Discussion

15:15-15:45 Coffee Break

15:45-16:45 Educational Session: Imaging COPD: From phenotyping to precision care
   Moderators: L. Mlynska, Jena/DE; N. Screaton, Cambridge/UK

Imaging phenotypes in COPD – Prerequisites for individualized treatment, E. Pompe, Utrecht/NL
Functional imaging in COPD – More than what meets the eye, M.O. Wielpütz, Greifswald/DE
The Big Blender – The many facets of smoking-related lung disease, M. Balbi, Turin/IT